Central vs. systemic neurotoxicity of hypoglycin (ackee toxin) and related substance in the cat
Borison, H.L.; Pendleton, J.; McCarthy, L.E.
Journal of Pharmacology and Experimental Therapeutics 190(2): 327-333
1974
ISSN/ISBN: 0022-3565 PMID: 4449044 Document Number: 77293
Document emailed within 1 workday
Related Documents
Chase, G.W.; Landen, W.O.; Soliman, A.G. 1990: Hypoglycin A content in the aril, seeds, and husks of ackee fruit at various stages of ripeness Journal - Association of Official Analytical Chemists 73(2): 318-319Duss, F.ço.-R.ég.; Voide, C. 2018: Toxin-infections and toxin-related diseases due to Clostridia other than Clostridium difficile Revue Medicale Suisse 14(622): 1795-1798
Landheim, A.S.; Bakken, K.; Vaglum, P. 2006: What characterizes substance abusers who commit suicide attempts? Factors related to Axis i disorders and patterns of substance use disorders. a study of treatment-seeking substance abusers in Norway European Addiction Research 12(2): 102-108
De Jong, R.H. 1980: Systemic neurotoxicity of local anesthetic Der Anaesthesist 29(10): 49-51
Licinio, J. 1997: Central nervous system cytokines and their relevance for neurotoxicity and apoptosis Journal of Neural Transmission. Supplementum 49: 169-175
Xu, J.; Purcell, W.M.; Ray, D.E. 2000: Age difference in the metabolism of p-bromophenylacetylurea in the rat: an implication for age-related susceptibility to its neurotoxicity Neurotoxicology 21(3): 289-293
West, M.E.; Sidrak, G.H. 1970: Some biological observations on hypoglycin-A in the presence of leucine West Indian Medical Journal 19(1): 19-24
Henry, J.L. 1979: Roles of peptides in central transmission: substance P, bradykinin and B-endorphin International Journal of Neurology 13(1-4): 167-179
Coppieters, I.; Ickmans, K.; Cagnie, B.; Nijs, J.; De Pauw, R.; Noten, S.; Meeus, M. 2015: Cognitive Performance Is Related to Central Sensitization and Health-related Quality of Life in Patients with Chronic Whiplash-Associated Disorders and Fibromyalgia Pain Physician 18(3): E389-E401
Hilse, H.; Piesche, L.; Scheer, E. 1974: Current problems in active substance research. 4. Central effects of angiotensin II Die Pharmazie 29(5): 303-306
Singer, E. 1984: Interaction of the neuropeptides substance P and neurotensin with central monoamine transmitter systems Wiener Klinische Wochenschrift 96(22): 809-816
Reshetniak, V.K.; Chuvin, B.T.; Durinian, R.A. 1985: Bioelectrical reactions of neurons of the central gray substance of the brain in response to electroacupuncture Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 5: 33-35
Gama, A.C.C.; Menezes, L.N.; Maia, A.A.; Rezende Neto, A.L.; Oliveira, J.B. 2010: Voice related quality of life after botulinum toxin injection for spasmodic dysphonia Revue de Laryngologie - Otologie - Rhinologie 131(1): 39-44
Elguero, J.; García-Antón, J.M.; Goya, P.; Haro, I.; Martínez, A.; Reig, F. 1989: Conformation-activity relationship in hexapeptides related to substance P Arzneimittel-Forschung 39(8): 835-838
Vagenas, P.; Azbel, L.; Polonsky, M.; Kerimi, N.; Mamyrov, M.; Dvoryak, S.; Altice, F.L. 2013: A review of medical and substance use co-morbidities in Central Asian prisons: implications for HIV prevention and treatment Drug and Alcohol Dependence 132 Suppl. 1: S25-S31
Yakimova, K.; Ovtcharov, R. 1988: Effect of the body temperature upon central administration of substance P--the role of adrenalectomy and GABA-activation Acta Physiologica et Pharmacologica Bulgarica 14(4): 65-70
Changgeng, Z.; Zenker, W.; Celio, M. 1983: Substance P--positive structures in rat spinal cord--a longitudinal bundle ventral to the central canal Anatomischer Anzeiger 154(3): 193-203
vanderSpek, J.C.; Sutherland, J.; Sampson, E.; Murphy, J.R. 1995: Genetic construction and characterization of the diphtheria toxin-related interleukin 15 fusion protein DAB389 sIL-15 Protein Engineering 8(12): 1317-1321
Rameshwar, P.; Gascon, P.; Ganea, D. 1993: Stimulation of IL-2 production in murine lymphocytes by substance P and related tachykinins Journal of Immunology 151(5): 2484-2496
Ito, S. 2014: Evidence based treatment for Shiga-toxin-producing E. coli related hemolytic uremic syndrome Nihon Jinzo Gakkai Shi 56(7): 1075-1081